Loretta Tse
About Loretta Tse
Loretta Tse (Year of Birth: 1967) serves as a Vice President of abrdn World Healthcare Fund (THW) and other Funds in the complex; she has held this officer role since 2024. She is currently an Investment Director at abrdn, having joined in October 2023 from Tekla Capital Management LLC, where she was a Vice President investing in venture; she previously worked at the Fred Hutchinson Cancer Research Center and Oxford Biosciences Partners . Fund documents state all officers are employees of abrdn Inc. (the administrator/adviser) and receive no compensation from any of the Funds; the Funds also have no bonus, profit sharing, pension or retirement plans, so no Fund-linked performance pay or TSR/financial metric linkage for officers is disclosed .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| abrdn | Investment Director | Since Oct 2023 | Senior investment role within abrdn’s healthcare Funds complex |
| Tekla Capital Management LLC | Vice President (venture investing) | Until Oct 2023 | Venture investing experience directly relevant to healthcare/life sciences |
| Fred Hutchinson Cancer Research Center | Not disclosed | Not disclosed | Scientific/healthcare domain experience (exact role not disclosed) |
| Oxford Biosciences Partners | Not disclosed | Not disclosed | Life sciences investing exposure (exact role not disclosed) |
External Roles
| Organization | Role | Years |
|---|---|---|
| None disclosed in the DEF 14A for Ms. Tse | — | — |
Fixed Compensation
All Fund officers are compensated by abrdn Inc. and do not receive compensation from THW or the other Funds; the Funds have no bonus, profit sharing, pension or retirement plans .
| Component | Fund-Paid? | Amount/Detail |
|---|---|---|
| Base Salary | No | Officers are paid by abrdn Inc.; no Fund amounts disclosed |
| Target Bonus % | No | Not disclosed; Funds have no bonus plans |
| Actual Bonus Paid | No | Not disclosed; Funds have no bonus plans |
| Pension/SERP | No | Funds have no pension or retirement plans |
| Perquisites | No | Not disclosed at Fund level |
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| None paid by THW (officers paid by abrdn Inc.; Fund has no bonus/profit-sharing) | — | — | — | — | — |
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Individual beneficial ownership (Ms. Tse) | Not disclosed in proxy |
| Trustees and officers aggregate beneficial ownership of THW | Less than 1% of outstanding equity securities (as of April 1, 2025) |
| THW shares outstanding (Record Date: April 7, 2025) | 39,849,957.6 shares |
| Vested vs. unvested shares; options (Ms. Tse) | Not disclosed |
| Shares pledged/hedged by officers | Not disclosed |
| Stock ownership guidelines (officers) | Not disclosed |
| Compliance with ownership guidelines | Not disclosed |
Employment Terms
| Provision | Detail |
|---|---|
| Officer title and start | Vice President of the Funds; officer since 2024 |
| Appointment/term | Officers hold positions until a successor is duly elected and qualified; officers are appointed annually by the Fund Board |
| Employment contract, severance, change-of-control | Not disclosed in Fund filings (officers are employees of abrdn Inc.) |
| Non-compete/non-solicit, garden leave, consulting post-termination | Not disclosed |
Investment Implications
- Pay-for-performance linkage at the Fund level is not applicable to officers: THW does not pay officer compensation, and the Funds have no bonus or pension plans; compensation terms are at abrdn Inc., outside Fund filings, limiting visibility into incentives tied to THW/portfolio performance .
- Alignment via direct equity ownership appears limited at the Fund level; aggregate ownership by Trustees and officers is under 1%, and individual officer holdings (including Ms. Tse) are not disclosed, reducing visible “skin-in-the-game” signals from Fund documents .
- Retention risk is anchored at abrdn rather than the Fund: no severance or change-of-control economics are disclosed for Fund officers; any retention levers or vesting schedules would be abrdn policies, not THW’s, and are not available in Fund filings .
- Trading signals from insider selling/vesting pressure are constrained: officers’ individual holdings and award schedules are not disclosed in the proxy; there are no itemized Section 16 holdings for officers in this document, so monitoring must rely on external Section 16/Form 4 disclosures if/when filed .
References:
Shares outstanding; record date data.
Officer roster and biography; Ms. Tse’s role, year of birth, background, appointment terms.
Ownership of securities; aggregate ownership by Trustees and officers.
Compensation discussion noting officers are paid by abrdn Inc. and Funds have no bonus/pension plans.
– Context on Fund structure and filings (for broader governance background; not specific to compensation).